{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:26:33Z","timestamp":1790483193226,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.xphs.2020.10.058","type":"journal-article","created":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T17:47:58Z","timestamp":1604339278000},"page":"292-300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Pre-Clinical Evaluation of a Modified Cyclodextrin-Based Nanoparticle for Intestinal Delivery of Liraglutide"],"prefix":"10.1016","volume":"110","author":[{"given":"Elena","family":"Presas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulay","family":"Tovar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Cu\u00f1arro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph P.","family":"O'Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitriona M.","family":"O'Driscoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.xphs.2020.10.058_bib1","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1517\/17425247.2014.924500","article-title":"Orally active-targeted drug delivery systems for proteins and peptides","volume":"11","author":"Li","year":"2014","journal-title":"Expet Opin Drug Deliv"},{"issue":"37","key":"10.1016\/j.xphs.2020.10.058_bib2","doi-asserted-by":"crossref","first-page":"9678","DOI":"10.1016\/j.biomaterials.2013.08.048","article-title":"Intestinal mucosa permeability following oral insulin delivery using core shell corona nanolipoparticles","volume":"34","author":"Li","year":"2013","journal-title":"Biomaterials"},{"issue":"12","key":"10.1016\/j.xphs.2020.10.058_bib3","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.4155\/tde.11.128","article-title":"Opportunities and challenges for oral delivery of hydrophobic versus hydrophilic peptide and protein-like drugs using lipid-based technologies","volume":"2","author":"Griffin","year":"2011","journal-title":"Ther Deliv"},{"key":"10.1016\/j.xphs.2020.10.058_bib4","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.addr.2016.06.006","article-title":"Pharmacokinetic, pharmacodynamic and biodistribution following oral administration of nanocarriers containing peptide and protein drugs","volume":"106","author":"Griffin","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"10.1016\/j.xphs.2020.10.058_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/2230-8210.77571","article-title":"Liraglutide: A review of its therapeutic use as a once daily GLP-1 analog for the management of type 2 diabetes mellitus","volume":"15","author":"Dharmalingam","year":"2011","journal-title":"Indian J Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.xphs.2020.10.058_bib6","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1007\/s00125-009-1472-y","article-title":"Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial","volume":"52","author":"Russell-Jones","year":"2009","journal-title":"Diabetologia"},{"issue":"9548","key":"10.1016\/j.xphs.2020.10.058_bib7","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/S0140-6736(06)69705-5","article-title":"The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes","volume":"368","author":"Drucker","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.xphs.2020.10.058_bib8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2147\/VHRM.S4039","article-title":"Potential of liraglutide in the treatment of patients with type 2 diabetes","volume":"5","author":"Deacon","year":"2009","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.xphs.2020.10.058_bib9","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.addr.2016.04.001","article-title":"Lipid-based nanocarriers for oral peptide delivery","volume":"106","author":"Niu","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"issue":"10","key":"10.1016\/j.xphs.2020.10.058_bib10","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1021\/cn3000372","article-title":"Click-modified cyclodextrins as nonviral vectors for neuronal siRNA delivery","volume":"3","author":"O'Mahony","year":"2012","journal-title":"ACS Chem Neurosci"},{"issue":"25","key":"10.1016\/j.xphs.2020.10.058_bib11","doi-asserted-by":"crossref","first-page":"4954","DOI":"10.1039\/c2ob25490e","article-title":"A\u00a0click chemistry route to 2-functionalised PEGylated and cationic \u03b2-cyclodextrins: co-formulation opportunities for siRNA delivery","volume":"10","author":"O'Mahony","year":"2012","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.xphs.2020.10.058_bib12","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jconrel.2018.07.045","article-title":"Physicochemical, pharmacokinetic and pharmacodynamic analyses of amphiphilic cyclodextrin-based nanoparticles designed to enhance intestinal delivery of insulin","volume":"286","author":"Presas","year":"2018","journal-title":"J\u00a0Control Release"},{"issue":"1","key":"10.1016\/j.xphs.2020.10.058_bib13","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jconrel.2013.03.004","article-title":"Gene silencing of TNF-alpha in a murine model of acute colitis using a modified cyclodextrin delivery system","volume":"168","author":"McCarthy","year":"2013","journal-title":"J\u00a0Control Release"},{"issue":"1-2","key":"10.1016\/j.xphs.2020.10.058_bib14","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ijpharm.2015.12.055","article-title":"A\u00a0novel, anisamide-targeted cyclodextrin nanoformulation for siRNA delivery to prostate cancer cells expressing the sigma-1 receptor","volume":"499","author":"Fitzgerald","year":"2016","journal-title":"Int J Pharm"},{"issue":"6","key":"10.1016\/j.xphs.2020.10.058_bib15","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1038\/nprot.2006.202","article-title":"Using circular dichroism spectra to estimate protein secondary structure","volume":"1","author":"Greenfield","year":"2007","journal-title":"Nat Protoc"},{"issue":"1","key":"10.1016\/j.xphs.2020.10.058_bib16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/00032710600952432","article-title":"Polyacrylamide gel electrophoresis of insulin","volume":"40","author":"Chi","year":"2007","journal-title":"Anal Lett"},{"key":"10.1016\/j.xphs.2020.10.058_bib17","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jconrel.2017.02.024","article-title":"Rational design of polyarginine nanocapsules intended to help peptides overcoming intestinal barriers","volume":"263","author":"Niu","year":"2017","journal-title":"J\u00a0Control Release"},{"issue":"1-2","key":"10.1016\/j.xphs.2020.10.058_bib18","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ijpharm.2013.02.050","article-title":"Amphiphilic polyallylamine based polymeric micelles for siRNA delivery to the gastrointestinal tract: in\u00a0vitro investigations","volume":"447","author":"Guo","year":"2013","journal-title":"Int J Pharm"},{"issue":"6","key":"10.1016\/j.xphs.2020.10.058_bib19","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/cbdd.12360","article-title":"Stability of bovine lactoferrin in luminal extracts and mucosal homogenates from rat intestine: a prelude to oral absorption","volume":"84","author":"Yao","year":"2014","journal-title":"Chem Biol Drug Des"},{"issue":"4","key":"10.1016\/j.xphs.2020.10.058_bib20","first-page":"36931","article-title":"Temperature and pH effects on insulin structure: a molecular dynamic approach ebola project view project hypoglycemic effectors for diabetes mellitus view project temperature and pH effects on insulin structure: a molecular dynamic approach","volume":"7","author":"Dayer","year":"2016","journal-title":"Artic Jentashapir J Heal Res"},{"issue":"2","key":"10.1016\/j.xphs.2020.10.058_bib21","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.colsurfb.2006.09.012","article-title":"Development and characterization of new insulin containing polysaccharide nanoparticles","volume":"53","author":"Sarmento","year":"2006","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"1","key":"10.1016\/j.xphs.2020.10.058_bib23","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.3762\/bjnano.6.145","article-title":"Peptide-equipped tobacco mosaic virus templates for selective and controllable biomineral deposition","volume":"6","author":"Altintoprak","year":"2015","journal-title":"Beilstein J Nanotechnol"},{"issue":"7","key":"10.1016\/j.xphs.2020.10.058_bib24","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41565-020-0693-6","article-title":"Zwitterionic micelles efficiently deliver oral insulin without opening tight junctions","volume":"15","author":"Han","year":"2020","journal-title":"Nat Nanotechnol"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235492030678X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235492030678X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:30:07Z","timestamp":1758360607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235492030678X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S002235492030678X"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2020.10.058","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pre-Clinical Evaluation of a Modified Cyclodextrin-Based Nanoparticle for Intestinal Delivery of Liraglutide","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2020.10.058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}